Navamedic Reports Promising Q4 2024 Results and Plans New Product Launches Navamedic ASA sees solid revenue growth and a vibrant pipeline in 2024 despite challenges, projecting continued expansion in the health sector.

Navamedic Reports Promising Q4 2024 Results and Plans New Product Launches #Norway #Oslo #Navamedic_ASA #Pharma_Growth #Eroxon_Launch